Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate as Adjuvant to Bupivacaine in Supraclavicular Block
NCT02752334Phase 2Completed
- Sponsor
- Magrabi Hospitals & Centers
- Start
- Sep 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium sulfate in postoperative pain, sponsored by Magrabi Hospitals & Centers. Primary endpoint: Sensory block duration at 12 hours. Started Sep 2015; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02752334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02752334.